CVE-2026-22186Bio-Formats <= 8.3.0 XXE in Leica XLEF Metadata Parser
Updated under an hour ago ()
Does this affect you?
It affects Open Microscopy Environment Bio-Formats and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Bio-Formats versions up to and including 8.3.0 contain an XML External Entity (XXE) vulnerability in the Leica Microsystems metadata parsing component (e.g., XLEF). The parser uses an insecurely configured DocumentBuilderFactory when processing Leica XML-based metadata files, allowing external entity expansion and external DTD loading. A crafted metadata file can trigger outbound network requests (SSRF), access local system resources where readable, or cause a denial of service during XML parsing.
- CVSS
- 4.6 MEDIUM (v4.0, CNA)CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N
- Weakness (CWE)
- CWE-611
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Modified
- Record last updated
- Oct 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Open Microscopy Environment Bio-Formats open_microscopy_environment:bio_formats (from the name) | through 8.3.0 | CNA record |
openmicroscopy bio-formats openmicroscopy:bio-formats | through 8.3.0 | NVD |
References
- https://seclists.org/fulldisclosure/2026/Jan/6technical-description, exploit
- https://github.com/ome/bioformats/security/advisories/GHSA-x9vc-qh97-8gjpvendor-advisory
- https://docs.openmicroscopy.org/bio-formats/product, release-notes
- https://www.vulncheck.com/advisories/bio-formats-xxe-in-leica-xlef-metadata-parserthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.